Galectin Therapeutics Inc

NASDAQ:GALT   4:00:00 PM EDT
1.19
+0.04 (+3.48%)
Earnings Announcements

Galectin Therapeutics Inc Posts Qtrly Loss Per Share of $0.14

Published: 11/14/2022 13:17 GMT
Galectin Therapeutics Inc (GALT) - Galectin Therapeutics Inc - Qtrly Loss per Share $0.14.
Further Company Coverage: Galto
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.17

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.21

More details on our Analysts Page.